uMotif

uMotif is a technology company specializing in eCOA/ePRO platforms designed to power clinical and real-world research. Their platform is uniquely designed to engage patients as active participants, driving high compliance rates and delivering high-quality data for studies of all sizes. uMotif's focus on patient-centered design is evident in their collaboration with patients and renowned design firm IDEO. They have a proven track record of success, evidenced by their numerous case studies and testimonials from satisfied customers.

uMotif's mission extends beyond simply providing a digital platform. They are committed to improving the quality of life for patients and advancing research for conditions like Parkinson's Disease and Glioblastoma. Their work with OurBrainBank, a patient-led initiative for Glioblastoma, highlights their dedication to empowering patients and driving innovation in research. uMotif's expertise in CNS research, coupled with their patient-focused approach, positions them as a leader in the field.

uMotif is a technology company dedicated to empowering patients and researchers through its innovative eCOA/ePRO and engagement platform. The company's mission is to transform the speed, quality and accuracy of data in clinical and real-world research by designing user-friendly technology that prioritizes patient needs and fosters high levels of engagement. They believe that by making research more accessible and engaging for participants, they can drive better outcomes for patients and contribute to the advancement of medical science.

uMotif prioritizes a patient-centric culture, emphasizing collaboration and innovation to improve the clinical trial experience for all stakeholders. They foster a culture of transparency and open communication, encouraging employees to raise concerns about potential breaches of their anti-bribery, anti-slavery, and anti-corruption policies. The company promotes a culture of continuous improvement, with a focus on providing a positive and engaging experience for patients, researchers, and sponsors.